Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Medtronic
Dow
Johnson and Johnson
McKinsey

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Acetaminophen, and when can generic versions of Hydrocodone Bitartrate And Acetaminophen launch?

Hydrocodone Bitartrate And Acetaminophen is a drug marketed by Mallinckrodt, Mikart, Anda Repository, Genus, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Vintage Pharms, Vistapharm, Wes Pharma Inc, Abhai Llc, Able, Actavis Labs Fl Inc, Alvogen Pine Brook, Amneal Pharms, Amneal Pharms Ny, Apil, Ascent Pharms Inc, Aurolife Pharma Llc, Barr, Caraco, Elite Labs Inc, Epic Pharma Llc, Halsey, Ivax Pharms, Lannett Co Inc, Mutual Pharm, Novel Labs Inc, Par Pharm, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sandoz, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Tris Pharma Inc, Ucb Inc, Upsher Smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, and Watson Labs Florida. and is included in one hundred and twenty-two NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND ACETAMINOPHEN is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Summary for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Drug patent expirations by year for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Recent Clinical Trials for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sun Pharma Advanced Research Company LimitedPhase 1
GrĂ¼nenthal GmbHPhase 1
Teva Branded Pharmaceutical Products, R&D Inc.Phase 3

See all HYDROCODONE BITARTRATE AND ACETAMINOPHEN clinical trials

Pharmacology for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Synonyms for HYDROCODONE BITARTRATE AND ACETAMINOPHEN
330988-71-1
ABT 712
ACETAMINOPHEN AND HYDROCODONE BITARTRATE
Acetaminophen mixture with Hydrocodone
Acetaminophen mixture with Hydrocodone bitartrate
D00846
Dolacet
Dolagesic
GQIVTWIJJVAWQR-DANDVKJOSA-N
Hyco-Pap
Hycomed
Hydroco/APAP
Hydrocodone / acetaminophen
Hydrocodone & acetaminophen combination
Hydrocodone bitartrate - acetaminophen mixt
Hydrocodone-APAP
Hydrocodone/acetaminophen
Hydrocodone/APAP
Hydrogesic
Liquicet
Lorcet
Lorcet 10/650
Margesic
Maxidone
Morphinan-6-one, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), mixt. with N-(4-hydroxyphenyl)acetamide
Polygesic
Stagesic
Theracodophen-325
Theracodophen-low-90
Vanacet
Vicodin CR
Vycavert
Xodol
Zolvit
Zydone

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040307-001 Jul 26, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 207172-003 Jun 22, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Alvogen Pine Brook HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 208540-001 Nov 8, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
Able HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 040477-001 Nov 6, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Medtronic
Merck
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.